Lamivudine (3TC)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lamivudine (3TC), covering 2013-07-29 to 2015-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP [Phase 3]